Melphalan

Nov 11, 2015

Long-Term Outcome of Patients with AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell Transplantation

In immunoglobulin light chain (AL) amyloidosis, amyloid fibril deposits, derived from immunoglobulin light chains produced by a clonal plasma cell dyscrasia,…

High Dose Chemotherapy With Melphalan and Autologous Stem Cell Transplantation (HDM-ASCT)

Subscribe to

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.